作为抗结核药物引起的肝毒性显著风险因素的NAT2缓慢乙化器表型:来自多民族嵌病例控制研究的结果
Stefania Cheli1, Alessandro Torre2, Marco Schiuma3
1ICPS, Pharmacovigilance & Clinical Research, Department of Biomedical and Clinical Sciences, ASST Fatebenefratelli Sacco, University Hospital Luigi Sacco, Università Degli Studi di Milano, Milan, Italy.
概括
N-乙转移酶2 (NAT2) 缓慢的乙化剂状态是结核患者药物诱导性肝损伤 (DILI) 的最佳预测指标. 这一发现可以帮助优化治疗和预防不同人群的肝损伤.
科学领域:
- 药物基因组学 药物基因组学
- 肝病学 肝病学是一种肝病学.
- 传染性疾病 传染性疾病
背景情况:
- 药物诱导性肝损伤 (DILI) 是结核病治疗的一个重要问题,发生率在2%至28%之间.
- 之前对抗结核病DILI的风险因素研究缺乏多民族,现实世界的数据.
- 确定可靠的预测因子对于预防不同患者群体的DILI至关重要.
研究的目的:
- 在多民族结核病患者队列中确定药物诱导性肝损伤 (DILI) 的最佳预测因素.
- 在现实临床环境中调查抗结核DILI的危险因素.
- 为结核病提供个性化治疗策略的信息.
主要方法:
- 在米兰Luigi Sacco医院的结核病诊所进行了一项嵌套病例控制研究.
- 纳入了102名患者,根据性别,年龄,BMI,诊断和索引日期,每个病例的2个对照对应.
- 评估N-乙转移酶2 (NAT2) 基因型作为潜在的预测因子.
主要成果:
- N-乙转移酶2 (NAT2) 缓慢的乙化剂状态被确定为DILI的最佳独立预测因子.
- 患有NAT2缓慢乙化器状态的患者患有DILI的几率明显更高 (OR,5.97;P = .02).
- 这一发现强调了基因因素对抗结核药物毒性的重要性.
结论:
- 根据NAT2基因型指导的剂量可能会优化抗结核病药物治疗方案.
- 基于NAT2状态的个性化剂量可以帮助预防治疗失败和DILI.
- 这种方法提供了一种在不同人群中更安全,更有效的结核病管理策略.
更多相关视频
相关概念视频
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Pulmonary Tuberculosis II
211
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211
Phase II Reactions: Acetylation Reactions
175
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
175
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis III
303
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
303
Pulmonary Tuberculosis IV
133
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
133


